Anaphore to collaborate with Mitsubishi Tanabe Pharma in autoimmune disease
This article was originally published in Scrip
Executive Summary
Anaphore, a privately-held US firm, has entered into a partnership with Mitsubishi Tanabe Pharma to develop protein therapies for autoimmune diseases.